Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et al
- PMID: 26193885
- DOI: 10.1093/annonc/mdv301
Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et al
Comment on
-
Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases.Ann Oncol. 2015 May;26(5):987-991. doi: 10.1093/annonc/mdv037. Epub 2015 Feb 16. Ann Oncol. 2015. PMID: 25688058 Free PMC article.
-
Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy.Ann Oncol. 2015 Oct;26(10):2196. doi: 10.1093/annonc/mdv287. Epub 2015 Jul 8. Ann Oncol. 2015. PMID: 26156078 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical